10 GMP consultants

Four of these GMP consultants are former FDA staff, with titles from field investigator and drug specialist to compliance officer and CBER reviewer, and eight now consult through firms where they are president, owner or principal. That mix suits a site preparing for an FDA pre-approval inspection, answering inspection findings, or getting a 503B outsourcing facility audit-ready.

10 professionals10 companiesData retrieved September 29, 2026

Professionals to explore

  1. David Ritchie

    LinkedIn

    Experience: Former Independent GMP Compliance Consultant & Auditor · Genentech

    David Ritchie is Director, Audit & Inspection Readiness at Enterey Life Sciences Consulting since 2025, and was an Independent GMP Compliance Consultant & Auditor at Genentech (2022–2025) and Assoc. Director (GxP), Corporate Global Compliance at BioMarin Pharmaceutical Inc. (2015–2022). Bilingual in English and French, David describes 30+ years supporting drug testing, manufacturing and quality systems, a fit for audit programs.

    Is this you? Claim your profile and get paid for calls.

  2. Douglas Campbell

    LinkedIn

    Experience: Owner and Principal · Campbell CGMP Services

    Owner and Principal at Campbell CGMP Services since 2026, Douglas Campbell was Senior Consultant at InterPro QRA (2012–2026). Douglas's US Food and Drug Administration titles were Drug Specialist (2005–2006), Compliance Officer (2006–2011) and Senior Policy Advisor (2011–2012), and the firm describes guiding pharmaceutical teams through inspections, enforcement strategies and quality risk management, a fit for enforcement questions.

    Is this you? Claim your profile and get paid for calls.

  3. Dr. Michael von Gönner

    LinkedIn

    Experience: Senior Quality Consultant Life Science · GMP Advice

    Dr. Michael von Gönner is Senior Quality Consultant Life Science at GMP Advice since 2024, offering inspection readiness support, interim management, audits and supplier and CMO management. Michael was Head of Quality Management at Phyton Biotech (2000–2024), Head of GMP Assurance there (1999–2000) and QA Manager at Catalent (1992–1999), and describes being cross-examined in many FDA and other authority inspections.

    Is this you? Claim your profile and get paid for calls.

  4. Ernesto Alfonso

    LinkedIn

    Experience: President & Principal GMP Consultant · Pharma Consulting Group International (PCGI)

    Ernesto Alfonso has been President & Principal GMP Consultant at Pharma Consulting Group International (PCGI) since 2019. At Wockhardt, Ernesto held Vice President - Head Corporate Quality Compliance and Remediation (2016–2018), Senior Vice President - Corporate Quality Compliance & Remediation (2018–2019), Senior Vice President - Quality (2019) and Quality Head at Wockhardt USA (2020–2021), the one to ask about company-wide GMP remediation.

    Is this you? Claim your profile and get paid for calls.

  5. Marie Morin

    LinkedIn

    Experience: President · MFM GMP Consulting

    Marie Morin is President of MFM GMP Consulting since 2016 and was Global QA Auditor at SGS (2014–2016). At FDA, Marie held Investigator (2002–2014), Level III Drug Investigator (2011–2014) and Drug Specialist (2012–2014), and describes inspecting pharmaceutical sites in the US and countries including China, India, Germany, Italy and Ireland, so questions on overseas site inspections fit here.

    Is this you? Claim your profile and get paid for calls.

  6. Michael Anisfeld, MBA, MSM, M.Sc., B. Pharm

    LinkedIn

    Experience: President andSenior GMP Compliance Consultant for Healthcare Manufacturing · Globepharm Consulting

    Michael Anisfeld, MBA, MSM, M.Sc., B. Pharm holds three President and Senior GMP Compliance Consultant titles at Globepharm Consulting since 1984, covering healthcare manufacturing, worldwide governments and agencies, and legal testimony expert witness work. Michael lists facility design, technology transfer and getting clients through FDA GMP inspections the first time, and is an Adjunct Faculty Member at University of Illinois Chicago.

    Is this you? Claim your profile and get paid for calls.

  7. Michael Magee

    LinkedIn

    Experience: Owner and Principal Consultant · Kenformete Solutions, LLC

    Since 2025, Michael Magee has been Owner and Principal Consultant at Kenformete Solutions, LLC, Lead Auditor, 503B Accreditation & GMP Compliance at Coalition for Compounding Excellence and Senior Associate at Gates Healthcare Associates, Inc. Michael was Vice President, Quality and Compliance at Tris Pharma (2024–2025), and describes advising pharma, biopharma and 503A/503B organizations on cGMP systems and inspection readiness.

    Is this you? Claim your profile and get paid for calls.

  8. Reginald Neal

    LinkedIn

    Experience: President Principal Consultant · RD NEAL LLC

    Reginald Neal has been President Principal Consultant at RD NEAL LLC since 2021 and was Senior Consultant at Biologics Consulting (2006–2021). Reginald's U.S. Food and Drug Administration roles include Senior Reviewer Consumer Safety Officer at CBER / OCBQ / DMPQ (1999–2006) and Reviewer Bio-Research Monitoring at CBER / OCBQ / DIS (1995–1999). Reginald describes GMP expertise across chemical, biopharmaceutical and medical device products.

    Is this you? Claim your profile and get paid for calls.

  9. Robert Jennings

    LinkedIn

    Experience: Principal Consultant · RWJ Consulting 4CGMP, LLC

    Robert Jennings has been Principal Consultant at RWJ Consulting 4CGMP, LLC since 2018, working with biotech firms on pre-approval inspection readiness, including a CAR T client with a successful FDA PLI result. Robert held GSK roles including Compliance Director (2015–2018) and Director GMP Compliance Auditing (2004–2014), and was a Field Investigator at FDA (1991–2004), a fit for gap assessments before a pre-approval inspection.

    Is this you? Claim your profile and get paid for calls.

  10. Ronald Britt

    LinkedIn

    Experience: Former Senior Consultant, GMP SME · Exemplar Compliance

    Ronald Britt is President and Owner of Britt Pharma Consulting, LLC since 2013, and was Senior Consultant, GMP SME at Exemplar Compliance (2015–2016) and Senior Consultant at Tunnell Consulting, Inc. (2013–2014). Ronald was Director Quality Assurance at MicroDose Therapeutx (2009–2012) and describes building and maintaining quality systems and cGMP compliance remediation, suited to questions on quality system design.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

To hear how an investigator reads a site, start with the four former FDA staff: Robert Jennings, Marie Morin, Douglas Campbell and Reginald Neal. For running remediation from inside a company, Ernesto Alfonso (Wockhardt quality and remediation), Michael Magee (Tris Pharma) and Dr. Michael von Gönner (Phyton Biotech) held the senior in-house quality titles. Robert Jennings and Reginald Neal also fit biologics and cell therapy work.

Questions to take into the conversation

  1. 01In a mock pre-approval inspection, which records and areas do you check first, and what tells you a site isn't ready?
  2. 02After an FDA investigator leaves with observations, how do you decide which commitments to make in the response and on what timeline?
  3. 03What do inspectors expect from a 503B outsourcing facility's quality system that a traditional drug manufacturer might already have?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals